1h Free Analyst Time
The publisher has been monitoring the autologous cell therapy market and it is poised to grow by $4.11 bn during 2021-2025, progressing at a CAGR of over 14% during the forecast period. The report on the autologous cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for effective drugs for cardiac and degenerative disorders, limitations in traditional organ transplantations fueling demand for stem cell therapies, and rise in funds for autologous stem cell therapy.
The autologous cell therapy market analysis includes the product segment and geographic landscape.
The autologous cell therapy market is segmented as below:
By Product
- Autologous stem cell therapy
- Autologous cellular immunotherapies
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increasing M&A activities as one of the prime reasons driving the autologous cell therapy market growth during the next few years. Also, the development of stem cell therapies by new regions and increasing focus on development of drugs for emerging applications will lead to sizable demand in the market.
The report on autologous cell therapy market covers the following areas:
- Autologous cell therapy market sizing
- Autologous cell therapy market forecast
- Autologous cell therapy market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autologous cell therapy market vendors that include Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Smith and Nephew plc, Sumitomo Chemical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Vericel Corp. Also, the autologous cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Autologous stem cell therapy - Market size and forecast 2020-2025
- Autologous cellular immunotherapies - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Bayer AG
- Brainstorm Cell Therapeutics Inc.
- Daiichi Sankyo Co. Ltd.
- FUJIFILM Holdings Corp.
- Holostem Terapie Avanzate Srl
- Smith and Nephew plc
- Sumitomo Chemical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vericel Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Autologous stem cell therapy - Market size and forecast 2020-2025 ($ million)
- Autologous stem cell therapy - Year-over-year growth 2020-2025 (%)
- Autologous cellular immunotherapies - Market size and forecast 2020-2025 ($ million)
- Autologous cellular immunotherapies - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- Brainstorm Cell Therapeutics Inc. - Overview
- Brainstorm Cell Therapeutics Inc. - Product and service
- Brainstorm Cell Therapeutics Inc. - Key offerings
- Brainstorm Cell Therapeutics Inc. - Key customers
- Brainstorm Cell Therapeutics Inc. - Segment focus
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Key customers
- Daiichi Sankyo Co. Ltd. - Segment focus
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Key customers
- FUJIFILM Holdings Corp. - Segment focus
- Holostem Terapie Avanzate Srl - Overview
- Holostem Terapie Avanzate Srl - Product and service
- Holostem Terapie Avanzate Srl - Key offerings
- Holostem Terapie Avanzate Srl - Key customers
- Holostem Terapie Avanzate Srl - Segment focus
- Smith and Nephew plc - Overview
- Smith and Nephew plc - Business segments
- Smith and Nephew plc - Key offerings
- Smith and Nephew plc - Key customers
- Smith and Nephew plc - Segment focus
- Sumitomo Chemical Co. Ltd. - Overview
- Sumitomo Chemical Co. Ltd. - Business segments
- Sumitomo Chemical Co. Ltd. - Key offerings
- Sumitomo Chemical Co. Ltd. - Key customers
- Sumitomo Chemical Co. Ltd. - Segment focus
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product and service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- Takeda Pharmaceutical Co. Ltd. - Key customers
- Takeda Pharmaceutical Co. Ltd. - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Vericel Corp. - Overview
- Vericel Corp. - Business segments
- Vericel Corp. - Key offerings
- Vericel Corp. - Key customers
- Vericel Corp. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global autologous cell therapy market: Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Smith and Nephew plc, Sumitomo Chemical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Vericel Corp.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing M&A activities.`
According to the report, one of the major drivers for this market is the increasing demand for effective drugs for cardiac and degenerative disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Brainstorm Cell Therapeutics Inc.
- Daiichi Sankyo Co. Ltd.
- FUJIFILM Holdings Corp.
- Holostem Terapie Avanzate Srl
- Smith and Nephew plc
- Sumitomo Chemical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vericel Corp.
